Systematic meta-analysis of the toxicities and side effects of the targeted drug lenvatinib
Lenvatinib is effective for cancer but toxic, and this study supports its rational clinical use.
Authors
- Jingfei Shi (ORCID: https://orcid.org/0000-0002-7879-9671)
- Kai Wang (ORCID: https://orcid.org/0000-0002-0137-1247)
- Huihui Liu (ORCID: https://orcid.org/0000-0001-5331-8264)
- Chao Cui
- Qingwei Li
- Yu Sun
- Shuai Gao
Institutions
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1080/07853890.2025.2598935
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00